Discrepancies in prevalence estimates in two national surveys for nonmedical use of a specific opioid product versus any prescription pain reliever

Drug and Alcohol Dependence

Volumn 134, Issue 1, 2014, Pages 396-400

  Biondo, Gabriella ^a,b   Chilcoat, Howard D ^b,c  

^a YALE UNIVERSITY   (United States)

^b PURDUE PHARMA L P   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Epidemiology; Opioid; Oxycodone; OxyContin; Pain reliever; Prevalence

Indexed keywords

CANNABIS; COCAINE; OPIATE; OXYCODONE;

ARTICLE; DRUG ABUSE; DRUG USE; HEALTH SURVEY; HUMAN; PAIN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; STRATEGIC PLANNING; TREND STUDY;

EPIDEMIOLOGY; OPIOID; OXYCODONE; OXYCONTIN; PAIN RELIEVER; PREVALENCE;

ADOLESCENT; ANALGESICS, OPIOID; DATA COLLECTION; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; PREVALENCE; YOUNG ADULT;

EID: 84890186719     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.10.005     Document Type: Article

References (9)

1. Brener N.D., Eaton D.K., Kann L., Grunbaum J.A., Gross L.A., Kyle T.M., Ross J.G. The association of survey setting and mode with self-reported health risk behaviors among high school students. Public Opin. Q. 2006, 70:354-374.
2. Brener N.D., Grunbaum J.A., Kann L., McManus T., Ross J. Assessing health risk behaviors among adolescents: the effect of question wording and appeals for honesty. J. Adolesc. Health 2004, 35:91-100.
3. Food and Drug Administration, 2013. Guidance for Industry: Abuse Deterrent Opioids-Evaluation and Labeling. Washington, DC.
4. Food and Drug Administration, 2013. Drug Safety and Risk Management Advisory Committee Meeting Briefing Document. Silver Spring, MD.
5. Johnston L.D., Bachman J.G., O'Malley P.M., Schulenberg J.E. Monitoring the Future: A Continuing Study of American Youth (12th-Grade Survey), 2010 2011, Inter-University Consortium for Political and Social Research, Ann Arbor, MI.
6. Martins S.S., Storr C.L., Zhu H., Chilcoat H.D. Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population. Drug Alcohol Depend. 2009, 99:58-67.
7. Meier E.A., Troost J.P., Anthony J.C. Extramedical use of prescription pain relievers by youth aged 12-21 years in the United States: national estimates by age and by year. Arch. Pediatr. Adolesc. Med. 2012, 166:803-807.
8. Substance Abuse and Mental Health Services Administration, 2011. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD.
9. Turner C.F., Ku L., Rogers S.M., Lindberg L.D., Pleck J.H., Sonenstein F.L. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science 1998, 280:867-873.